Login to Your Account


Adimab's Gerngross explains company's partnering success

Monday, July 14, 2014

Adimab LLC is not the typical biotech. It's a venture-backed, yet profitable company that has made its name as a partner of choice for antibody drug discovery. In fact, Adimab recently inked a deal for its 50th program, which is particularly impressive given that the firm only began partnering activities about five years ago.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription